vexol
Pharmaranks rates Vexol 3.5/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Vexol (Rimexolone) is a medication used to treat Inflammation, Anterior Uveitis.
Rimexolone · by Harrow Eye
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Rimexolone
- Form
- Drops
- Strength
- Rimexolone 1%
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- May treat
- inflammation, anterior uveitis
- Manufacturer
- Harrow Eye
- FDA application
- NDA020474
- Availability
- Discontinued (per FDA)
May treat (source: NIH RxClass)
- inflammation
- anterior uveitis
Dosage forms
Drops
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Vexol treat?
- Vexol (Rimexolone) may be used to treat inflammation, anterior uveitis, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How is Vexol rated?
- pharmaranks gives Vexol a composite score of 3.5 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- Is there a coupon or discount for Vexol?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Vexol. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Vexol?
- Vexol is marketed by Harrow Eye. You can see Harrow Eye's full profile, rating, and other products on pharmaranks.
- Is Vexol a brand-name or generic drug?
- Vexol is a brand-name product with the active ingredient Rimexolone.
- Is Vexol available over the counter?
- No. Vexol is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Vexol come in?
- Vexol is currently marketed as drops, per the FDA's National Drug Code Directory.
- Is Vexol FDA-registered?
- Vexol is on record with the U.S. FDA under application number NDA020474. You can verify this on its official FDA label.
- Has Vexol been recalled by the FDA?
- Vexol has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Vexol safe?
- There's no single safe-or-not verdict. pharmaranks gives Vexol a recall-safety score of 70/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about RIMEXOLONE
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 40 reports naming RIMEXOLONE — the active ingredient in Vexol, and the FDA flagged 93% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- constipation7 reports
- dry mouth7 reports
- dyspnoea7 reports
- sinus bradycardia7 reports
- somnolence7 reports
- urinary retention7 reports
- cataract6 reports
- tenderness6 reports
Read these as a signal, not a rate. A report does not mean RIMEXOLONE caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 26, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
acular
Ketorolac Tromethamine
acular ls
Ketorolac Tromethamine
asmanex hfa
Mometasone Furoate
clocortolone pivalate
Clocortolone Pivalate
desonide
Desonide
desoximetasone
Desoximetasone
Compare Vexol head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
vexol
70/100